Defining a CMV viral load threshold for pre-emptive therapy in paediatric haematopoietic stem cell transplant recipients

Further Publications

Workforce consensus recommendations for paediatric haematopoietic stem cell transplant centres on behalf of the Paediatric Sub-Committee of the British Society of Blood and Marrow Transplantation and Cellular Therapy

Br J Haematol

Elfeky R, Broderick V, Ewins AM, Rivers E, Roberts W, Slatter M, Guest J, Hill A, Samrin L, Mclelland V, Holden V, Gardiner B, Sealy L, Waller L, Betteridge C, Tholouli E, Lee J, Broome H, Blundell Jones J, Prescott N, Hudson N, Hurrell R, Rao K, Gibson B, James B

doi: 10.1111/bjh.70230

Leukemia

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

Br J Haematol

Buchbinder N, Michel V, Dalissier A, Kleinschmidt K, Locatelli F, Maschan A, Wynn R, Fagioli F, Zecca M, Jubert C, Versluys B, Sedlacek P, Zubarovskaya L, Gonzalez Vicent M, Biffi A, Michel G, Mirci-Danicar O, Holter W, Ansari M, Galimard JE, Schneider P, Abouqateb M, Kałwak K

doi: 10.1111/bjh.70167

Further Publications

Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline

EClinicalMedicine

Phillips R, Fisher BT, Ladas EJ, Patel P, Robinson PD, Dupuis LL, Ammann RA, Beauchemin MP, Carlesse F, Castagnola E, Davis BL, Efremov K, Elgarten CW, Groll AH, Haeusler GM, Koenig C, Morris A, Santolaya ME, Spinelli D, Tissing WJE, Wolf J, Sung L, Lehrnbecher T

doi: 10.1016/j.eclinm.2025.103093

Leukemia

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation

Br J Haematol

Perutelli F, Boccellato E, Montalbano MC, Catania G, Deodato M, Frustaci AM, Innocenti I, Moia R, Quaglia FM, Quaresmini G, Rivela P, Gaidano G, Krampera M, Laurenti L, Rambaldi A, Bruno B, Vitale C, Coscia M

doi: 10.1111/bjh.19976

Lymphoma

Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201

Leuk Lymphoma

Andreadis C, Bobek O, Hsi ED, Fenske TS, Stiff PJ, Hill BT, Geyer SM, Horwitz M, Khimani F, Little RF, Dinner SN, Friedberg JW, Kahl BS, Perales MA, Devine SM, Leonard JP, Bartlett NL

doi: 10.1080/10428194.2025.2525982

Further Publications

Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCRαβ/CD19 depletion or post-transplant cyclophosphamide

Br J Haematol

Masetti R, Leardini D, Gottardi F, Baccelli F, Ottaviano GAM, Vendemini F, Saglio F, Pierri F, Algeri M, Del Bufalo F, Merli P, Prete A, Cesaro S, Ussowicz M, Faraci M, Zecca M, Fagioli F, Balduzzi A, Dalle JH, Locatelli F, Pagliara D

doi: 10.1111/bjh.70004

Leukemia

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy

Br J Haematol

Konuma T, Shimomura Y, Mizuno S, Yamasaki S, Yui S, Uchida N, Doki N, Tanaka M, Yoshihara S, Eto T, Katayama Y, Katsuoka Y, Tokunaga M, Ota S, Sakata-Yanagimoto M, Ishiwata K, Kanda Y, Kawakita T, Onizuka M, Kanda J, Fukuda T, Atsuta Y, Yanada M

doi: 10.1111/bjh.20208

Lymphoma

Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study

Br J Haematol

Severinsen FT, Simonsen MR, Futtrup Maksten E, Jakobsen LH, Jensen RK, Søgaard KK, Jensen P, Brown PN, Mészáros Jørgensen J, Larsen TS, Poulsen CB, El-Galaly TC

doi: 10.1111/bjh.20262

Further Publications

Adverse Impact of Pre-Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation

Am J Hematol

Misaki Y, Tamaki M, Yanagisawa R, Doki N, Uchida N, Tanaka M, Nishida T, Sawa M, Hasegawa Y, Ota S, Onizuka M, Mamiko SY, Katayama Y, Asada N, Kanda J, Fukuda T, Atsuta Y, Kanda Y, Yakushijin K, Nakasone H

doi: 10.1002/ajh.27652

Related content

Workforce consensus recommendations for paediatric haematopoietic stem cell transplant centres on behalf of the Paediatric Sub-Committee of the British Society of Blood and Marrow Transplantation and Cellular Therapy

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation

Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCRαβ/CD19 depletion or post-transplant cyclophosphamide

Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy

Late infections after high-dose therapy and autologous stem cell transplantation for lymphoma: A Danish population-based study

Adverse Impact of Pre-Transplant Liver Dysfunction in Allogeneic Hematopoietic Cell Transplantation